Osteoarthritis Treatment Guidelines

Introduction to Osteoarthritis Management

The American College of Rheumatology and NICE guidelines strongly recommend against using glucosamine for osteoarthritis treatment, as the highest quality evidence with the lowest risk of bias shows no clinically meaningful benefit over placebo 1, 2
The 2019 American College of Rheumatology/Arthritis Foundation guidelines explicitly state that data with the lowest risk of bias fail to show any important benefits of glucosamine over placebo for pain relief or disease modification 1
NICE guidelines explicitly state that "the use of glucosamine and chondroitin products is not recommended" 1
The American Academy of Orthopaedic Surgeons strongly recommends against glucosamine use for knee osteoarthritis 2

Physical activity and exercise programs (local muscle strengthening and general aerobic fitness) are recommended as first-line non-pharmacological approaches 1, 4
Weight loss interventions for patients with BMI ≥25 kg/m² are recommended as first-line non-pharmacological approaches 1, 4
Self-management programs with patient education are recommended as first-line non-pharmacological approaches 4

Acetaminophen (paracetamol) up to 4000 mg/day is recommended as initial analgesic therapy 1, 4
Topical NSAIDs are recommended for localized joint pain, particularly knee and hand osteoarthritis (fewer systemic side effects than oral NSAIDs) 1, 4
Topical capsaicin is recommended as an alternative topical agent 1
Oral NSAIDs or COX-2 inhibitors at the lowest effective dose for the shortest duration, with mandatory proton pump inhibitor co-prescription in elderly patients, are recommended as second-line options 4
Tramadol (with or without acetaminophen) is recommended as an alternative oral analgesic 3

No placebo-controlled trials of glucosamine have been performed specifically in hand osteoarthritis 3
Chondroitin sulfate may be used specifically for hand osteoarthritis based on one well-performed trial showing symptom relief 3, 5
The American Geriatrics Society guideline from 2001 is outdated, and current guidelines from 2019-2025 recommend against the use of glucosamine 1, 2, 6